Deans' stroke musings: Guidelines for Management of Ischaemic Stroke 2008 European Stroke Org.

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, January 7, 2012

Guidelines for Management of Ischaemic Stroke 2008 European Stroke Org.

At least the Europeans have something like this published and available to the public, if the US has something similar it is well hidden. 151 pages of powerpoint, page 125 has this: Calling it by the bland name of neuroprotection, rather than the more alarming and correct- stopping the neuronal cascade of death. If we don't use the term death, we aren't assigning enough priority to finding a solution to it.

•No adequately sized trial has yet shown significant effect in predefined endpoints for any neuroprotective substance
•A meta-analysis has suggested a mild benefit for citocoline1
Then why is edaravone approved in Japan(since 2001)?
http://www.google.co.in/url?sa=t&rct=j&q=best%20physiotherapy%20approach%20for%20stroke&source=web&cd=76&ved=0CEcQFjAFOEY&url=http%3A%2F%2Fwww.eso-stroke.org%2Fppt%2FESO08_Slides_25thApril.PPT&ei=wbgIT-6HDIatgwes78mzAw&usg=AFQjCNFmHw0837aCyxT_OWd4Kvc2Sk6QJA&cad=rja
And on page 145 they also use the worthless term;

•Multidisciplinary stroke team for rehabilitation

In all these pages they never once listed all the problems that need to be corrected in stroke research, rehabilitation.